Publication | Open Access

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10−/− mice by attenuating the activation of T cells and promoting their apoptosis

InflammationChronic Inflammatory DiseasesCannabinoid Receptor-2Il-10−/− MiceInflammatory DiseaseMucosal ImmunologyMedicineImmune RegulationImmunologyT Cell ImmunityImmune FunctionInnate ImmunityUlcerative ColitisT CellsPharmacologyCannabinoid Pharmacology